Opportunities

Associate General Counsel

This key legal role to support the Company, specifically the legal department and legal-related functions, such as Human Resources, in the preparation, review and negotiation of corporate contracts, creation of templates, review of documents with legal implications, corporate governance and board matters, and other legal matters.

Responsibilities

 

  • Key team member in the review and preparation of the Company’s public reports including the earnings press release, quarterly supplemental analyst package and SEC filings (Forms 10-K, 10-Q, Proxy, 8-K, Form 4 etc.).
  • Review and preparation of consolidated financial statements, footnotes and related supporting schedules in accordance with U.S. GAAP and SEC requirements.
  • Key team member in the implementation of SOX, ERM, ESG initiatives
  • Provide ad hoc reporting to Executive Management team, as needed.
  • Participate in the coordination of various department projects as applicable to continue to build efficiencies.
  • Review analyses prepared by other team members.
  • Must have solid experience negotiating complex agreements from the start to finish, e.g., license agreements, acquisition agreements, etc.
  • Prepare, review and negotiate legal documents such as confidentiality agreements, clinical agreements, master services agreements, consulting agreements, and commercial agreements.
  • Creation of template agreements.
  • Assist other departments with legal related matters, such as Human Resources.
  • Maintain and organize minute books.
  • Assist with Board-related projects and activities.
  • Monitor legal matters with outside counsel.
  • Other corporate work as needed by General Counsel

 

Competencies Required:

  • Attorney: JD degree, Bachelor’s degree.  Recent law school graduate awaiting bar results, or recently licensed attorney with   5+ years of Legal experience.
  • Experience in the Healthcare Industry is a plus.
  • Solid knowledge of legal principles and practices.
  • Thorough knowledge of legal contracting principles.
  • Strong knowledge of local, state and federal laws and regulations governing medical devices/pharmaceutical practices.
  • Relevant computer software knowledge and experience.
  • Qualifications/Knowledge/Experience Required:
  • Negotiation skills
  • Teamwork
  • Strong individual contributor

 

Organizational Relationship Authority: Report to General Counsel

 

IMPORTANT SAFETY INFORMATION (United States)

INDICATIONS FOR USE: The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds. The RECELL® device is used by an appropriately-licensed healthcare professional at the patient’s point of care to prepare autologous RES® Regenerative Epidermal Suspension for direct application to acute partial-thickness thermal burn wounds in patients 18 years of age and older or application in combination with meshed autografting for acute full-thickness thermal burn wounds in pediatric and adult patients.

CONTRAINDICATIONS: RECELL® is contraindicated for: the treatment of wounds clinically diagnosed as infected or with necrotic tissue, the treatment of patients with a known hypersensitivity to trypsin or compound sodium lactate (Hartmann’s) solution, patients having a known hypersensitivity to anesthetics, adrenaline/epinephrine, povidone-iodine, or chlorhexidine solutions.

WARNINGS AND PRECAUTIONS: Autologous use only. Wound beds treated with a cytotoxic agent (e.g., silver sulfadiazine) should be rinsed prior to application of the cell suspension. RECELL® is provided sterile and is intended for single-use. Do not use if packaging is damaged or expired. Choose a donor site with no evidence of cellulitis or infection and process skin immediately. A skin sample should require between 15 and 30 minutes contact with Enzyme. Contact in excess of 60 minutes is not recommended. RECELL® Enzyme is animal derived and freedom from infectious agents cannot be guaranteed.

PRECAUTIONS: RECELL® is not intended for use without meshed autograft for treatment of full-thickness burn wounds. The safety and effectiveness of RECELL® without meshed autograft have not been established for treatment of partial-thickness burn wounds: on the hands and articulating joints, >320 cm2, in patients with wounds totaling >20% total body surface area (TBSA). The safety and effectiveness of RECELL with autografting have not been established for treatment of full-thickness burn wounds: on the hands and articulated joints, and in patients younger than 28 days of age (neonates).

SPECIAL PATIENT POPULATIONS: The safety and effectiveness of RECELL® have not been established for treatment of acute thermal partial-thickness burn wounds in pediatric patients younger than 18 years of age.

For complete Important Safety Information, refer to Instructions For Use. Please be aware that any indication for RECELL® outside of the United States may differ from the US indication. Please see the Instructions for Use for each country for the specific indication of RECELL®.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company.
©Copyright 2022 AVITA Medical. All Rights Reserved.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company.
©Copyright 2022 AVITA Medical. All Rights Reserved.